Objectives: This study was conducted to investigate the clinical significance of Slit2 and Robo1 expression in prognosis of patients with brain gliomas.
Methods: Human brain tissue samples were collected from normal glial tissues (control), low- and high-grade glioma tissues. Slit2 and Robo1 expression levels in cells were assessed by an immunohistochemistry (IHC), and population of the Slit2- and Robo1-presenting patients was examined. The Slit2 and Robo1 mRNA expression levels in three types of the brain cells was determined by RT-PCR.
Results: Slit2 cell counts were decreased with increased Robo1 cells in the low-grade and high-grade glioma tissues as compared to the control. The percentage of cells expressing Slit2 decreased from the control to the high-grade glioma and the percentage of cells expressing Robo1 in low- and high-grade gliomas was increased as compared to the control (P < 0.01). The decrease in the Slit2 mRNA expression was associated with the increase in the Robo1 mRNA expression in the low- and high-grade gliomas (P < 0.01 or 0.05). Survival time for patients with Slit2/Robo1 gliomas was shorter than patients with Slit2/Robo1 gliomas in the investigated cohorts (P < 0.01).
Conclusion: Slit2 and Robo1 expression levels serve as a biomarker with utility in grading gliomas as well as predicting patient survival. The change in Slit2 expression is more reliable and effective than Robo1 expression in predicting a poor prognosis of brain glioma patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.suronc.2016.09.003 | DOI Listing |
Neurobiol Dis
December 2024
Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA 92354, USA; Department of Anesthesiology, Loma Linda University, CA 92354, USA; Department of Neurosurgery, Loma Linda University, CA 92354, USA. Electronic address:
Sci Transl Med
November 2024
Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.
Roundabout (ROBO) 1 and 2 are transmembrane receptors that bind secreted SLIT ligands through their extracellular domains (ECDs) and signal through their cytoplasmic domains to modulate the cytoskeleton and regulate cell migration, adhesion, and proliferation. SLIT-ROBO signaling regulates pathological ocular neovascularization, which is a major cause of vision loss worldwide, but pharmacological tools to prevent SLIT-ROBO signaling are lacking. Here, we developed human monoclonal antibodies (mAbs) against the ROBO1 and ROBO2 ECDs.
View Article and Find Full Text PDFPhytomedicine
December 2024
School of Traditional Chinese Medicine, Capital Medical University, Beijing, China; Beijing Key Lab of TCM Collateral Disease Theory Research, Beijing, China. Electronic address:
MicroPubl Biol
September 2024
University of California, Santa Cruz, CA, USA.
Curr Opin Endocrinol Diabetes Obes
October 2024
Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Purpose Of Review: Evolving understanding of thyroid eye disease (TED) has led to rapidly advancing therapeutic options. Most new treatments under development or recently available to patients are predicated on insights into disease mechanism.
Recent Findings: TED, a disfiguring process, involves inflammation and remodeling of the connective tissues around the eye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!